Double-Blind, Placebo-Controlled Study of Amantadine Hydrochloride in the Treatment of Children With Autistic Disorder

Bryan H. King(University of Pittsburgh), Edwin H. Cook(University of Illinois Chicago), Benjamin L. Handen(Kennedy Krieger Institute), Martin J. Lubetsky(University of Pittsburgh), Andrew W. Zimmerman(Kennedy Krieger Institute), STEPHEN R. HOOPER(University of Pittsburgh), Pablo Davanzo(University of Pittsburgh), Elisa S. Shernoff(Kennedy Krieger Institute), Scott M. Myers(University of Pittsburgh), Linmarie Sikich(University of Pittsburgh), Bennett Leventhal(Nathan Kline Institute for Psychiatric Research), Elisabeth M. Dykens(Vanderbilt University), Catherine Lord(University of California, Los Angeles), Colin T. Dourish(HR Wallingford), Jennifer Levitt(Kennedy Krieger Institute), William McMahon(University of Pittsburgh), ERIN CANTWELL(Kennedy Krieger Institute), Bhavik Shah(Kennedy Krieger Institute), D. MARK WRIGHT(Kennedy Krieger Institute), KWANNA WILLIAMSON(University of Pittsburgh), CATHERINE A. JASELSKIS(University of Pittsburgh), MICHAEL SNAPE(University of Pittsburgh), Sally Ozonoff(University of California, Davis)

Journal of the American Academy of Child & Adolescent Psychiatry

June 1, 2001

Cited by 196

Related Papers

|Molecular Psychiatry|2013|2.8k

|Nature Reviews Disease Primers|2020|1.6k

|Neuron|2015|1.5k

|PEDIATRICS|2011|1.4k

|Neurology|2000|1.1k